Press Releases

Pulmonary Hypertension Association of Canada Applauds Canada’s Drug Agency Recommendation for Public Funding of Winrevair™ (sotatercept)

New Study Released for World PH Day Shows Huge Impact of Rare and Complex Lung Disease on Canadians

PHA Canada Welcomes Federal Government Investment to Support Access to Rare Disease Drugs

Raising Awareness of Pulmonary Hypertension One Story at a Time: Pulmonary Hypertension Association

National Survey Reveals Need for Innovation in Care and Treatment of Rare Lung Disease

Canadian PH Community Survey Demonstrates the Resiliency of People Affected by Rare Disease Pulmonary Hypertension

First Pulmonary Hypertension Patient to Chair National Association